Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
330 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06760221 | Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities | recruiting | N/A | 20 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06749691 | Liposomal Irinotecan and Apatinib in ES-SCLC(LIAES) | recruiting | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER |
| 1 |
| Dec 27, 2024 |
| clinicaltrials |
| NCT06683820 | Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques | completed | — | 3 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06587789 | Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer | recruiting | — | 286 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT06643689 | Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms(TAPES) | not yet recruiting | Phase 2 | 394 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06671249 | Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery | not yet recruiting | N/A | 184 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06464913 | Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction | recruiting | Phase 2 | 152 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT03716596 | SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients(CISPD-2) | terminated | Phase 1 | 8 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT06590948 | Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS | unknown | — | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06595966 | Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery | recruiting | — | 80 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06523673 | Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer(OPPRESS) | recruiting | Phase 3 | 104 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT05875584 | Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection | completed | — | 598 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06554561 | A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma | recruiting | Phase 1 / Phase 2 | 43 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06554600 | A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma | recruiting | Phase 2 | 36 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06556186 | Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma | not yet recruiting | N/A | 600 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Aug 15, 2024 | clinicaltrials |
| NCT06157359 | Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection | unknown | N/A | 84 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06464874 | Endoscopic Therapy for Laterally Spreading Tumors (LSTs)(LST) | completed | — | 890 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT06385717 | Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer(ESCORT) | recruiting | — | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT05735028 | The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer | unknown | Phase 1 | 8 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05926492 | A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma | unknown | Phase 2 | 160 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06106152 | WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody | unknown | Early Phase 1 | 20 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06317480 | Outcomes Comparison Between Bone Resection and Subperiosteal Dissection for Specific Type of Soft Tissue Sarcoma | completed | — | 142 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Mar 19, 2024 | clinicaltrials |
| NCT05593146 | A Randomized Controlled Study Evaluating Modified Cup Anteversion Placement in Prevention of Postoperative Dislocation in Patients Undergoing Acetabular Tumor Resection and Reconstruction | recruiting | Phase 2 | 118 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06290817 | Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI | unknown | Phase 2 | 62 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06240689 | A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood | recruiting | Phase 2 | 104 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT05640778 | Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER) | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06195111 | A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study) | not yet recruiting | — | 200 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jan 8, 2024 | clinicaltrials |
| NCT06134765 | Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer | unknown | Phase 2 | 89 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05785325 | RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT05307198 | Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC(RAIC) | unknown | Phase 2 | 38 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05990231 | Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy | unknown | Phase 2 | 35 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06011993 | Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC） | unknown | — | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT05914389 | Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer(ICONIC) | recruiting | Phase 2 | 100 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05160896 | SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer | unknown | Phase 2 | 90 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05894837 | Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05841849 | Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer | not yet recruiting | Phase 4 | 1,028 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05212454 | Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks | recruiting | Phase 3 | 400 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05816629 | Multiparameter Ultrasound Based-AI for the Diagnosis of Thyroid Nodules(AI) | unknown | — | 2,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05718128 | Clinical Study of Endocardial Myocardial Biopsy | recruiting | Phase 4 | 100 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT03732664 | ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer | completed | Phase 1 | 27 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05776732 | Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion | unknown | N/A | 165 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT04194359 | Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer | unknown | Phase 2 | 25 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT05595603 | Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage | recruiting | Phase 2 | 153 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT04483804 | Application of Radiomics in Breast Cancer | recruiting | — | 2,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05759858 | Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma | unknown | — | 100 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05760430 | The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma | unknown | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05758025 | A New Surgical Strategy to Protect the Inferior Parathyroid | unknown | N/A | 506 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT05755685 | Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial | unknown | Phase 2 | 10 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05649475 | Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy | unknown | — | 100 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 24, 2023 | clinicaltrials |
| NCT05742425 | Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases | recruiting | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 24, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials